检测心脏受损标志物ELISA试剂盒，用于动物心血管研究

来源：seebio.cn作者：西宝生物人气：-发表时间：2013-08-22 13:57:00【大中小】

检测心脏受损标志物ELISA试剂盒

心脏受损时就会释放心脏生物标志物到血液中，检测生物标志物的水平可指示心脏受损的程度。标志物比如心肌肌钙蛋白-I是专一用于检测心脏受损的标志物，而肌红蛋白，脂肪酸结合蛋白和MLC-1升高也是骨骼肌受损的结果。在人体中，肌红蛋白和脂肪酸结合蛋白是高于基线的标志物，心脏受损后2-4h增加就可以测定，9-12h达到高峰，24-36h又回到基线。心肌肌钙蛋白-I在4-6h超过基线，12-24h达到高峰，6-10天仍然会升高。我们一般的经验是动物心脏标志物在受损（1-2h）快速达到高峰，在1-2天又回到基线。

西宝生物供应美国进口心肌肌钙蛋白-I，肌红蛋白，脂肪酸结合蛋白和肌球蛋白轻链-1.小鼠，大鼠，兔，狗和猴的试剂盒，用于这些物种的心血管研究。自2003年我们的试剂盒就得到了广泛应用，并在科学文献中广泛引用。在2011年11月份我们推出了一系列超灵敏的心肌肌钙蛋白-I 试剂盒，能够用于血清和血浆中重要生物标志物的检测，超灵敏的试剂盒是高灵敏试剂盒的4倍。我们的目标是提供高质量产品，加速新的心血管药物和诊治策略的开发。

ELISA试剂盒相关产品：

ELISA Kit(96-well kit)	范围 (ng/ml)	中文名称	产品编号
Mouse Cardiac Tn-I (for serum)	0.156 – 10	小鼠心肌肌钙蛋白-I ELISA试剂盒（用于血清）	ADM0709A
Mouse Cardiac Tn-I (for plasma)	0.156 – 10	小鼠心肌肌钙蛋白-I ELISA试剂盒（用于血浆）	ADM0710A
Mouse Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1	0.039 – 2.5	小鼠心肌肌钙蛋白-I 超灵敏ELISA试剂盒（用于血浆或血清）	ADM0711A
Rat Cardiac Tn-I (for serum)	0.156 – 10	大鼠心肌肌钙蛋白-I ELISA试剂盒（用于血清）	ADM0712A
Rat Cardiac Tn-I (for plasma)	0.156 – 10	大鼠心肌肌钙蛋白-I ELISA试剂盒（用于血浆）	ADM0713A
Rat Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1	0.039 – 2.5	大鼠心肌肌钙蛋白-I 超灵敏ELISA试剂盒（用于血浆或血清）	ADM0714A
Dog Cardiac Tn-I (for serum)	0.156 – 10	狗心肌肌钙蛋白-I ELISA试剂盒（用于血清）	ADM0715A
Dog Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1	0.039 – 2.5	狗心肌肌钙蛋白-I 超灵敏ELISA试剂盒（用于血浆或血清）	ADM0716A
Pig Cardiac Tn-I (for serum)	0.039 – 2.5	猪心肌肌钙蛋白-I ELISA试剂盒（用于血清）	ADM0717A
Pig Cardiac Tn-I (for plasma)	0.039 – 2.5	猪心肌肌钙蛋白-I ELISA试剂盒（用于血浆）	ADM0718A
Pig Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1	0.0156 – 1.0	猪心肌肌钙蛋白-I 超灵敏ELISA试剂盒（用于血清或血浆）	ADM0719A
Monkey Cardiac Tn-I (for serum)	0.156 – 10	猴心肌肌钙蛋白-I ELISA试剂盒（用于血清）	ADM0720A
Monkey Cardiac Tn-I, Ultra Sensitive (for serum or plasma)1	0.039 – 2.5	猴心肌肌钙蛋白-I 超灵敏ELISA试剂盒（用于血清或血浆）	ADM0721A
Rabbit Cardiac Tn-I (for serum)	0.156 – 10	兔心肌肌钙蛋白-I ELISA试剂盒（用于血清）	ADM0722A
RabbitCardiac Tn-I, Ultra Sensitive (for serum or plasma)1	0.0195 – 1.25	兔心肌肌钙蛋白-I超灵敏 ELISA试剂盒（用于血清）	ADM0723A
Guinea Pig Cardiac Tn-I (for serum)	0.2 – 12.5	豚鼠心肌肌钙蛋白-I ELISA试剂盒（用于血清）	ADM0724A
ELISA Kit （96-well kit）	范围(ng/ml)	中文名称	产品编号
Mouse Myoglobin (for serum, plasma, & urine)	3.9 – 250	小鼠肌红蛋白ELISA试剂盒（用于血清，血浆和尿）	ADM0726A
Rat Myoglobin (for serum, plasma, & urine)	1.56 – 100	大鼠肌红蛋白ELISA试剂盒（用于血清，血浆和尿）	ADM0727A
Rabbit Myoglobin (for serum, plasma, & urine)	2 – 125	兔肌红蛋白ELISA试剂盒（用于血清，血浆和尿）	ADM0728A
Dog Myoglobin (for serum, plasma, & urine)	3.9 – 250	狗肌红蛋白ELISA试剂盒（用于血清，血浆和尿）	ADM0729A
Pig Myoglobin (for serum, plasma, & urine)	0.5 – 31.25	猪肌红蛋白ELISA试剂盒（用于血清，血浆和尿）	ADM0730A
Monkey Myoglobin (for serum, plasma, & urine)	2 – 125	猴肌红蛋白ELISA试剂盒（用于血清，血浆和尿）	ADM0731A
Guinea Pig Myoglobin (for serum, plasma, & urine)	1.56 – 100	豚鼠肌红蛋白ELISA试剂盒（用于血清，血浆和尿	ADM0732A
ELISA Kit （96-well kit）	范围 (ng/ml)	中文名称	产品编号
Mouse Cardiac FABP (for serum & urine)	0.31 – 20	小鼠心肌叶酸结合蛋白ELISA试剂盒（用于血清和尿）	ADM0733A
Rat Cardiac FABP (for serum & urine)	0.078 – 5	大鼠心肌叶酸结合蛋白ELISA试剂盒（用于血清和尿）	ADM0734A
Dog Cardiac FABP (for serum & urine)	0.31 – 20	狗心肌叶酸结合蛋白ELISA试剂盒（用于血清和尿）	ADM0735A
Pig Cardiac FABP (for serum & urine)	0.78 – 25	猪心肌叶酸结合蛋白ELISA试剂盒（用于血清和尿）	ADM0736A
Rabbit Cardiac FABP (for serum & urine)	1.56 – 100	兔心肌叶酸结合蛋白ELISA试剂盒（用于血清和尿）	ADM0737A
Monkey Cardiac FABP (for serum)	3.9 – 250	猴心肌叶酸结合蛋白ELISA试剂盒（用于血清和尿）	ADM0738A
ELISA Kit （96-well kit）	范围 (ng/ml)	中文名称	产品编号
Rat & Mouse Cardiac MLC-1 (for serum)	0.078 – 2.5	大鼠&小鼠心肌肌球蛋白轻链-1ELISA试剂盒（用于血清）	ADM0739A

使用我们的动物肌钙蛋白-I,肌红蛋白，脂肪酸结合蛋白试剂盒结果见下图。血浆取自于兔心脏局部缺血前，缺血中及再灌注后，下图就体现出各自标志物的水平。和人的临床表现相同，肌红蛋白和脂肪酸结合蛋白在肌钙蛋白-I增加之前增加，并且肌钙蛋白-I比肌红蛋白和脂肪酸结合蛋白增加的时间要长。

以下所列为使用我们试剂盒发表的文献：

Mouse cTnI Publications

Tajiri K, et al.Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice. Cardiovasc Drugs Ther.[Epub ahead of print] (2013)
Antoniak S, et al.PAR-1 contributes to the innate immune response during viral infection. J Clin Invest. [Epub ahead of print] (2013)http://www.jci.org/articles/view/66125
Butcher A, et al.An allosteric modulator of the adenosine A1 receptor improves cardiac function following ischaemia in murine isolated hearts. Pharmaceuticals. 6(4):546-556 (2013)http://www.mdpi.com/1424-8247/6/4/546
Taghiabadi E, et al.Protective effect of silymarin against acrolein-induced cardiotoxicity in mice. Evid Based Complement Alternat Med. 352091 (2012)http://www.hindawi.com/journals/ecam/2012/352091/
Foy KC, et al. Immunotherapy with HER-2 and VEGF peptide mimics plus metronomic paclitaxel causes superior antineoplastic effects in transplantable and transgenic mouse models of human breast cancer. OncoImmunology. 1(7):1-13 (2012) http://www.landesbioscience.com/journals/53/article/21057/
Zhang Y, et al. The comparison of α-bromo-4-chlorocinnamaldehyde and cinnamaldehyde on coxsackie virus B3-induced myocarditis and their mechanisms. Int Immunopharmacol. 14(1):107-113 (2012)
Bhushan S, et al. Selective β2-Adrenoreceptor Stimulation Attenuates Myocardial Cell Death and Preserves Cardiac Function After Ischemia-Reperfusion Injury. Arterioscler Thromb Vasc Biol. 32(8):1865-1874 (2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401356/
Predmore BL, et al. The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability. Am J Physiol Heart Circ Physiol. 302(11):H2410-8 (2012)
De Meyer SF, et al. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice. Blood. [Epub ahead of print] (2012)
Peart JN, See Hoe L, Pepe S, Johnson P and Headrick JP. Opposing effects of age and calorie restriction on molecular determinants of myocardial ischemic tolerance. Rejuvenation Res. 15(1):59-70 (2012)
Kean TJ, et al. Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell. J Drug Target. 20(1): 23-32 (2012)
Xu Z, Desai M, Philip J, Sivsubramanian N,BowlesNEand Vallejo JG. Conditional transgenic expression of TIR-domain-containing adaptor-inducing interferon-β (TRIF) in the adult mouse heart is protective in acute viral myocarditis. Basic Res Cardiol. 106(6):1159-1171 (2011)
Kiraly A, Koffman B, Hacker M, Gunning W, Rasche S, Quinn A. A novel aza-anthrapyrazole blocks the progression of experimental autoimmune encephalomyelitis after the priming of autoimmunity. Clin Immunol. 141(3):304-316 (2011)
Ling Y, Pong T, Vassiliou CC, Huang PL and Cima MJ. Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers. Nat Biotechnol. 29(3):273-277 (2011)
Xu B, Strom J and Chen QM. Dexamethasone induces transcriptional activation of Bcl-xL gene and inhibits cardiac injury by myocardial ischemia. Eur J Pharmacol. 668(1-2):194-200 (2011)
Braunersreuther V, et al. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice. J Mol Cell Cardiol. 48(4):789-798 (2010)
Haas MS, Alicot EM, Schuerpf F, Chiu I, Li J, Moore FD and Carrol MC. Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovascular Research 87:618-627 (2010)
Maas JE, Wan TC, Figler RA, Gross GJ and Auchampach JA. Evidence that the acute phase of ischemic preconditioning does not require signaling by the A 2B adenosine receptor. J Mole Cell Cardiol. 49(5):886-893 (2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958103/
Cao Z, Hu Y, Wu W, Ha T, Kelley J, Deng C, Chen Q, Li J and Li Y. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischemia/reperfusion injury. Cardiovascular Research 84:442-451 (2009)
Engle SK, et al. Qualification of cardiac troponin-I concentration in mouse serum using isoproterenol and implementation in pharmacology studies to accelerate drug development. Toxicologic Pathology 37:617-628 (2009)
Qi D, Hu X. Wu X, Merk M, Leng L, Bucala R and Young LH. Cardiac Macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J Clin Invest. 119:3807-3816 (2009)
Richer MJ, Lavallée DJ, Shanina I, Horwitz MS. Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection. PLoS ONE 4(1): e4127. doi:10.1371/journal.pone.0004127 (2009)
Atkinson C., et al. Complement-dependent inflammation and injury in a murine model of brain dead donor hearts. Circulation Research. 105:1094-1101 (2009)
Buyse MG, et al. Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. Eurpoean Heart Journal 30:116-124 (2009)
Elrod JW et.al. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. PNAS 104:15560-15565 (2007)
Eckle T, et al. Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A2B Adenosine Receptors. Circulation 115:1581-1590 (2007)
Eckle T, et al. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ. Physiol. 291:H2533-H2540 (2006)
Hardarson HS, et al. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am J Physiol Heart Circ. Physiol 292:H251-H258 (2006)
Madonna R, Rinaldi L, Rossi C, Geng Y-J and De Caterina R. Prostacyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells. Clinical Research 27:2054-2061 (2006)
Morrison RR, Tan XL, Ledent C, Mustafa SJ and Hifmann PA. Targeted deletion of A2Aadenosine receptors attenuates the protective effects of myocardial postconditioning. Am J Physiol Heart Circ Physiol. 293:H2523-H2529 (2007)
Engle,SKet al. Strain differences in serum cardiac troponin-I concentration and myocardial necrosis after isoproterenol treatment in mice. Abstract No. 383. The Toxicologist CD — An official Journal of the Society of Toxicology, Volume 96, Number S-1 (2007)
Hou G, Dick R, Zeng C, Brewer GJ. Comparison of lowering copper levels with tetrathiomolybdate and zinc on mouse tumor and doxorubicin models. Translational Research 148:309-314 (2006)
Huber SA, Feldman AM and Sartini D. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-a transgenic mice. Circ Res. 99:1109-1116 (2006)
Mullick A, Leon Z, Min-Oo G, Berghout J, Lo R, Daniels E and Gros P. Cardiac failure in C5-deficient mice after Candida albicans infection. Infection and Immunity. 74(8):4439-4451 (2006)Hou G, Dick R, Abrams GD, Brewer GJ., Tetrathiomolybdate protects against cardiac damage by doxorubicin in mice. J Lab Clin Med.146(5):299-303 (2005Tao L, Liu H-R, Gao F, Qu Y, Christopher TA, Lopez BL and Ma XL. Mechanical traumatic injury without circulatory shock causes cardiomyocyte apoptosis: rol of reactive nitrogen and reactive oxygen species. Am J Heart Circ Physiol. 288:H2811-H2818 (2005)

Rat cTnI Publications

Yeh CH, et al.Potent cardioprotection from ischemia-reperfusion injury by a 2-domain fusion protein comprising Annexin V and Kunitz protease inhibitor.J Thromb Haemost.doi: 10.1111/jth.12314 (2013)
Doods H and Wu D.Sabiporide reduces ischemia-induced arrhythmias and myocardial infarction and attenuates ERK phosphorylation and iNOS induction in rats. BioMed Res Int. 2013:504320 (2013)http://www.hindawi.com/journals/bmri/2013/504320/
Ke D, Fang J, Fan L, Chen Z, Chen L.Regulatory T cells contribute to rosuvastatin-induced cardioprotection against ischemia-reperfusion injury.Coron Artery Dis. [Epub ahead of print] (2013)
Watts JA, Gellar MA,FulkersonMB, Kline JA.A soluble guanylate cyclase stimulator, BAY 41-8543, preserves right ventricular function in experimental pulmonary embolism.Pulm Pharmacol Ther. [Epub ahead of print] (2012)
Cheng K, et al. Magnetic enhancement of cell retention, engraftment and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant. 21(6):1121-1135 (2012) http://www.ingentaconnect.com/content/cog/ct/2012/00000021/00000006/art00006
Juneman EB, Saleh L, Lancaster JJ, Thai HM,MarkhamB and Goldman S. The effects of poloxamer-188 on left ventricular function in chronic heart failure after myocardial infarction. J Cardiovasc Pharmacol. 60(3):293-298 (2012)
Govindan S, et al. Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol. 52(1):154-164 (2012)
Huang CH, et al. Acute cardiac dysfunction after short-term diesel exhaust particles exposure. Toxicol Lett. 192(3):349-355 (2012)
Shin IW, et al. Myocardial protective effect by ulinastatin via an anti-inflammatory response after regional ischemia/reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol. 61(6):499-505 (2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249573/
Li T, et al. Polymerized human placenta hemoglobin given before ischemia protects rat heart from ischemia reperfusion injury. Artif Cells Blood Substit Immobil Biotechnol. 39(6):392-397 (2011)
Zisa D, et al. Intramuscular VEGF activates an SDF1-dependent progenitor cell cascade and an SDF1-independent muscle paracrine cascade for cardiac repair. Am J Physiol Heart Circ Physiol. 301(6):H2422-2432 (2011)
Shin IW, et al. Propofol has delayed myocardial protective effects after a regional ischemia/reperfusion injury in an in vivo rat heart model. Korean J Anesthesiol. 58(4):378-382 (2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876860/
Todorova VK, Kaufman Y, Hennings LJ and Klimberg VS. Glutamine regulation of doxorubicin accumulation in hearts versus tumors in experimental rats. Cancer Chemother Pharmacol 66:315-323 (2010)
Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y and Iwai N. Plasma miR-208 as a Biomarker of Myocardial Injury. Clin Chem. 55(11):1944-1949 (2009)
Yue T-L, et.al. In vivo activation of peroxisome proliferator-activated redeptor-d protects the heart from ischemia/reperfusion injury in Zucker fatty rats. J. Pharm. Exp. Ther. 325:466-474 (2008)
Zagorski J, Gellar MA, Obraztsova M, Kline JA andWattsJA. Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats. The Journal of Immunology 179:7820-7826 (2007)
Legare JF, Oxner A, Heimrath O, Myers T and Currie RW. Heat Shock treatment results in increased recruitment of labeled PMN following myocardial infarction. Am J Physiol Heart Circ Physiol. 293(5):H3210-5 (2007)
Chopra M and Sharma AC. Distinct cardiodynamic and molecular chracteristics during early and late stages of sepsis-induced myocardial dysfunction. Life Sciences. epub. July 2007
Liu J, Pang Y, Chang T, Bounelis P,ChathamJC, and Marchase RB. Increased hexoseamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia. J Mol. Cell Cardiol. 40 303-312 (2006)
Wang P and Chatham JC. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286:E725-E736 (2004)

Rabbit cTnI Publications

Booth EA, and Lucchesi BR. Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 293(3):H1408-15 (2007)
Lauver DA, Booth EA, White AJ, Poradosu E & Lucchesi BR. Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. J Pharm. Exp. Ther. 312(2):794-800 (2005)
Lauver DA, Lockwood SF and Lucchesi BR. Disodium disuccinate astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion. J Pharm. Exp. Ther. 314(2):686-692 (2005)
Booth EA, Obeid NR and Lucchesi BR. Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 289(5):H2039-47 (2005)

Pig cTnI Publications

Uitterdijk A, et al.Serial measurement of hFABP and high sensitivity Troponin I post PCI in STEMI. How fast and accurate can Myocardial Infarct Size and No-Reflow be predictedAm J Physiol Heart Circ Physiol. [Epub ahead of print] (2013)
Wu D, Kraut J, and Abraham WM.Sabiporide improves cardiovascular function, decreases the inflammatory response and reduces mortality in acute metabolic acidosis in pigs. PLoS one. 8(1): e53932 (2013)http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0053932
Wu D and Qi J. Mechanisms of the beneficial effect of NHE1 inhibitor in traumatic hemorrhage: inhibition of inflammatory pathways. Resuscitation. 83(6):774-781 (2012)
Gill RS, et al. Cyclosporine treatment improves cardiac function and systemic hemodynamics during resuscitation in a newborn piglet model of asphyxia: a dose-response study. Crit Care Med. 40(4): 1237-1244 (2012)
Bebarta VS, et al. Hydroxocobalamin and Epinephrine Both Improve Survival in a Swine Model of Cyanide-Induced Cardiac Arrest. Ann Emerg Med. [Epub ahead of print] (2012)
Wu D, Qi J, Dai H, Doods H and Abraham WM. Resuscitation with Na+/H+ exchanger inhibitor in traumatic haemorrhagic shock: cardiopulmonary performance, oxygen transport and tissue inflammation. Clin Exp Pharmacol Physiol. 37(3):337-342. (2010)
Liu J-Q, Lee T-F, Bigam DL and Cheung P-Y. Effects of post-resuscitation treatment with N-acetylcysteine on cardiac recovery in hypoxic newborn piglets. PLoS one 5(12): e15322 (2010)
Osipov RM, et al. Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass. Interactive CardioVascular and Thoracic Surgery 10: 506-512 (2010)
Adams JA, et al. Periodic acceleration (pGz) prior to whole body ischemia reperfusion injury provides early cardioprotective preconditioning. Life Sciences 86: 707-715 (2010)
Wu D, Bassuk J, Arias J, Doods H andAdamsJA. Cardiovascular effects of Na+/H+ exchanger inhibition with BIIB513 following hypovolemic circulatory shock. Shock 23(3):269-274 (2005)

Monkey cTnI Publications

Minimo H, et al. Characteristics of troponins as myocardial damage biomarkers in cynomolgus monkeys. J Toxicol Sci. 34(6): 589-601 (2009)

Mouse Myoglobin Publications

Nogales-Gadea G, et al. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. Brain. 135(Pt 7): 2048-2057 (2012)
Ling Y, Pong T, Vassiliou CC, Huang PL, Cima MJ. Implantable magnetic relaxation sensors measure cumulative exposure to cardiac biomarkers. Nat Biotechnol. 29(3):273-277 (2011)

Rat Myoglobin Publications

Ohta M, Kawano H, Notsu T, Naba H and Imada K. Eicosapentaenoic acid attenuates statin-induced ER stress and toxicity in myoblast. Biochem Biophys Res Commun. 424(2):301-307 (2012)
Kerkweg U, Pamp K, Fieker J, Petrat F, Hider RC and de Groot H. Release of redox-active iron by muscle crush trauma: no liberation into the circulation. Shock. 33(5):513-518 (2010) http://journals.lww.com/shockjournal/Fulltext/2010/05000/Release_of_Redox_Active_Iron_By_Muscle_Crush.11.aspx

Rat Cardiac FABP Publications

Hasic S, et al. Heart-type fatty acid-binding protein and its relation with morphological changes in rat myocardial damage model induced by isoproterenol. Bosn J Basic Med Sci. 11(4):240-244(2011) http://bjbms.org/archives/2011/4/240

应用声明：所有产品仅用于科研，不能应用于诊断和治疗。

其他产品：